Obesity Trial, Recruiting (NCT04526743)

Obesity Trial, Recruiting NCT04526743 Sponsor: GOSEEN Obesity group of the Spanish Endocrinology Society Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT04526743 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who were scheduled to have their first bariatric (weight loss) surgery between September 2020 and September 2021
People with severe obesity (a body mass index over 40) who are not suitable candidates for weight loss surgery
People who use the internet regularly
The types of weight loss surgery included are gastric bypass and sleeve gastrectomy (two common surgical procedures)
People who agree to take part in the study and sign a consent form

Who may not be able to join:

People who have previously had weight loss surgery, or who are having a second or follow-up surgery
People who are pregnant
People who have an intellectual disability that would make it difficult to complete the psychological questionnaires used in the study
People who have Type 1 diabetes
People who have dyslexia

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lilliam Flores, PhD, Obesity Unit, Endocrinology and Nutrition Department

Phone: 0034658023562

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04526743

Sponsor: GOSEEN Obesity group of the Spanish Endocrinology Society

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 0034658023562

More information: https://clinicaltrials.gov/study/NCT04526743

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who were scheduled to have their first bariatric (weight loss) surgery between September 2020 and September 2021
People with severe obesity (a body mass index over 40) who are not suitable candidates for weight loss surgery
People who use the internet regularly
The types of weight loss surgery included are gastric bypass and sleeve gastrectomy (two common surgical procedures)
People who agree to take part in the study and sign a consent form

Who may not be able to join:

People who have previously had weight loss surgery, or who are having a second or follow-up surgery
People who are pregnant
People who have an intellectual disability that would make it difficult to complete the psychological questionnaires used in the study
People who have Type 1 diabetes
People who have dyslexia

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

GOSEEN Obesity group of the Spanish Endocrinology Society

Registry

ClinicalTrials.gov

Start date

1 September 2019

Est. completion

1 September 2021

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Total weight lost percent (%).; Excess weight lost: percent (%),; Total weight regained: percent (%); Excess of weight regain: percent (%).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov